Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding

SJ Simmonds, I Cuijpers, S Heymans, EAV Jones - Cells, 2020 - mdpi.com
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF
can be classified into three groups based on the percentage of the ejection fraction (EF) …

[HTML][HTML] Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress

X Zhang, Y Zheng, Z Wang, J Gan, B Yu, B Lu… - Biomedicine & …, 2023 - Elsevier
The vascular endothelium is vital in maintaining cardiovascular health by regulating
vascular permeability and tone, preventing thrombosis, and controlling vascular …

[HTML][HTML] Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure

GM Gager, D von Lewinski, H Sourij, B Jilma… - Biomedicine & …, 2021 - Elsevier
Abstract Sodium-glucose cotransporter 2 (SGLT2) inhibitors present a class of antidiabetic
drugs, which inhibit renal glucose reabsorption resulting in the elevation of urinary glucose …

Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player

M Wesseling, JHC de Poel, SCA de Jager - ESC Heart Failure, 2020 - Wiley Online Library
Heart failure is a growing health issue as a negative consequence of improved survival
upon myocardial infarction, unhealthy lifestyle, and the ageing of our population. The large …

Novel insights regarding nitric oxide and cardiovascular diseases

T Infante, D Costa, C Napoli - Angiology, 2021 - journals.sagepub.com
Nitric oxide (NO) is a powerful mediator with biological activities such as vasodilation and
prevention of vascular smooth muscle cell proliferation as well as functional regulation of …

Hydrogen sulfide modulates endothelial–mesenchymal transition in heart failure

Z Li, H Xia, TE Sharp III, KB LaPenna… - Circulation …, 2023 - Am Heart Assoc
Background: Hydrogen sulfide is a critical endogenous signaling molecule that exerts
protective effects in the setting of heart failure. Cystathionine γ-lyase (CSE), 1 of 3 hydrogen …

Gut microbiota and derived short-chain fatty acids are linked to evolution of heart failure patients

J Modrego, A Ortega-Hernández… - International journal of …, 2023 - mdpi.com
There is a lack of direct evidence regarding gut microbiota dysbiosis and changes in short-
chain fatty acids (SCFAs) in heart failure (HF) patients. We sought to assess any association …

Molecular mechanisms and therapeutic implications of endothelial dysfunction in patients with heart failure

V Tsigkou, E Oikonomou, A Anastasiou… - International Journal of …, 2023 - mdpi.com
Heart failure is a complex medical syndrome that is attributed to a number of risk factors;
nevertheless, its clinical presentation is quite similar among the different etiologies. Heart …

Risk-based approach for the prediction and prevention of heart failure

A Sinha, DK Gupta, CW Yancy, SJ Shah… - Circulation: Heart …, 2021 - Am Heart Assoc
Targeted prevention of heart failure (HF) remains a critical need given the high prevalence
of HF morbidity and mortality. Similar to risk-based prevention of atherosclerotic …

Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases

J Bessa, A Albino-Teixeira, M Reina-Couto, T Sousa - Clinica Chimica Acta, 2020 - Elsevier
The vascular endothelium is localized at the interface between the blood and surrounding
tissues, playing a pivotal role in the maintenance of tissue-fluid homeostasis and in the …